<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01040923</url>
  </required_header>
  <id_info>
    <org_study_id>SM-C102</org_study_id>
    <nct_id>NCT01040923</nct_id>
  </id_info>
  <brief_title>Comparison of Digital Electronic Stethoscope to Computed Tomography (CT) Angiography in Detection of Coronary Artery Disease</brief_title>
  <official_title>Validation of the Cardiosond Sonospectrographic Digital Electronic Stethoscope in Diagnosing Coronary Artery Disease Versus CT Angiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SonoMedica, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>North Shore University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SonoMedica, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to evaluate the predictive diagnostic accuracy of SonoMedica's&#xD;
      CardioSond digital electronic stethoscope in the detection of coronary artery disease (CAD)&#xD;
      in patients without known disease who are referred to cardiac computed tomography angiography&#xD;
      (CT scans).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The CardioSond is a completely noninvasive medical device which detects heart sounds and&#xD;
      murmurs using ultrasensitive acoustic technology. The CardioSond produces a flow micro bruit&#xD;
      score which is used to determine the likelihood of coronary artery disease.&#xD;
&#xD;
      The CardioSond exam will be given to patients who agree to participate in the study upon&#xD;
      signing of an informed consent form and prior to the administration of beta blocker agents&#xD;
      and / or vasodilators as part of the normal cardiac CT angiography protocol.&#xD;
&#xD;
      CardioSond data will be sent to an independent acoustic core lab which will determine data&#xD;
      quality and produce a flow micro bruit score. CT angiography data will be analyzed by staff&#xD;
      at North Shore University Hospital.&#xD;
&#xD;
      A data review panel lead my the principal investigator will examine the results of both the&#xD;
      CardioSond and CT angiography data to determine the accuracy of the CardioSond in detecting&#xD;
      CAD in the study population at large and in specific patient subgroups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the CardioSond digital electronic stethoscope's flow micro bruit score as an indication of the probability of coronary artery disease in patients without know disease versus the results of cardiac CT angiography.</measure>
    <time_frame>Post collection of CardioSond and CT angiography data</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of CardioSond's flow micro bruit score as an indication of the probability of coronary artery disease against the results of cardiac CT angiography in patient subgroups including age, sex, body mass index, location and severity of disease.</measure>
    <time_frame>Upon collection of CardioSond and CT angiography data</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Cardiac CT</arm_group_label>
    <description>All patients in the study will be those presenting themselves for cardiac CT angiography who meet the proper inclusion / exclusion criteria</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CardioSond Cardiac Sonospectrographic Analyzer</intervention_name>
    <description>The CardioSond is a completely noninvasive, FDA 510(k) cleared digital electronic stethoscope designed to detect heart sounds and murmurs using ultrasensitive acoustic technology.</description>
    <arm_group_label>Cardiac CT</arm_group_label>
    <other_name>CardioSond</other_name>
    <other_name>CSA</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will be sourced from patients presenting themselves for cardiac CT&#xD;
        angiography who meet appropriate inclusion / exclusoin criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects who are undergoing routine screening coronary CT angiography&#xD;
&#xD;
          -  Willingness to sign informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to provide informed consent form&#xD;
&#xD;
          -  Age less than 21 years&#xD;
&#xD;
          -  Any contraindications to coronary CT angiography&#xD;
&#xD;
          -  Known atherosclerotic heart disease, including a history of prior myocardial&#xD;
             infarction, percutaneous coronary intervention, coronary artery bypass graft surgery&#xD;
             or an established diagnosis of CAD by prior X-ray or CT angiography&#xD;
&#xD;
          -  Supraventricular or ventricular arrhythmias that would be expected to affect&#xD;
             CT-angiography image quality (e.g., atrial fibrillation, atrial flutter, ventricular&#xD;
             tachycardia, bigeminy, and trigeminy). Patients with isolated premature atrial&#xD;
             contractions and premature ventricular contractions may enroll.&#xD;
&#xD;
          -  Use of intravenous vasodilators&#xD;
&#xD;
          -  Any pulmonary conditions that would create abnormal physical findings that would&#xD;
             interfere with the fidelity of the cardiac sound recording (e.g., obstructive&#xD;
             pulmonary disease, such as asthma or COPD, with audible wheezing).&#xD;
&#xD;
          -  Presence of audible aortic or pulmonic diastolic murmurs, tricuspid or mitral flow&#xD;
             diastolic murmurs, or continuous murmurs&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amgad N Makaryus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Shore University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Diane Dellilune, RN</last_name>
    <role>Study Director</role>
    <affiliation>North Shore University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.northshorelij.com/NSLIJ/nsuh</url>
    <description>North Shore University Hospital website</description>
  </link>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>December 29, 2009</study_first_submitted>
  <study_first_submitted_qc>December 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2009</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CAD</keyword>
  <keyword>Diagnostic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

